Suganuma I

No ORCID on file · 5 papers in corpus
other 2026
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2026.100488

OBJECTIVE: This study describes the examination procedure and clinical outcomes of hysterosalpingo-contrast sonography (HyCoSy) with perflubutane used as the ultrasound contrast agent for tubal patency evaluation. METHODS: Infertile women …

lab-animal 2014
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-2525

CONTEXT: Endometriosis is an estrogen-dependent disease, and estrogen is overproduced by abnormally elevated aromatase in endometriotic tissues. Peroxisome proliferator-activated receptor gamma, coactivator 1α (PGC-1α) is a transcriptional …

lab-animal 2012
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2012.08.023

OBJECTIVES: Low-dose estrogen-progestin (LEP) agents are often used for relieving endometriosis-associated chronic pelvic pain, but a direct effect of LEP on endometriotic lesions remains to be demonstrated. The objective of this study is t…

lab-animal 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.11.005

OBJECTIVE: To determine the effect of dienogest (DNG) on the expression of aromatase and cyclooxygenase-2 (COX-2) and the production of prostaglandin E(2) (PGE(2)) in human endometriotic stromal cells (ESCs). DESIGN: Experimental study in …

nonrandomized-trial 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.03.012

OBJECTIVE: To examine whether long-term administration of dienogest following gonadotropin-releasing hormone agonist (GnRH-a) therapy would prolong the relief of pelvic pain while reducing the amount of irregular uterine bleeding. STUDY DE…